… subsequent studies, the group has developed recombinant … Open label phase II study (NCT02090101)
evaluated the … in the phase III study of Bermekimab versus placebo (each with …

… of lung cancer, the induction of antitumor immunity from immune cells … administration will
be hindered by antiviral immunity. Some … of intraoperative direct intratumoral injection of HF10 …

… One such example, in the activation antiviral CD8 T cells by … an OV equipped with proteins
to enhance its anti-tumor activity. … In a study of 15 patients with colorectal cancer, IV infusion of …

… About 66 and 61% of stage II and III colon and rectal patients … inimical effects on antiviral
and antitumor immunity (112). … between CEA-CAR-T cells in addition to recombinant human …

… system from inhibitory signals and restore the anti-tumor … antiviral response pathways to
which the HSV-1 protein … with metastatic TNBC or colorectal cancer with liver metastasis have …

… In addition to potent antiviral activities in the frontline of … to evaluate the anticancer activity
of this cytokine 21 . High-dose … the treatment of chemorefractory metastatic colorectal cancer (…

… of selective anti-tumor activity of recombinant adenoviruses … with avelumab in patients with
colorectal cancer [171]. The … potentiate anti-tumor immune response by retargeting antiviral …

… barriers, and antiviral host immunity during its delivery [10]. … has shown enhanced antitumor
activity [32]. Recent published data … phase II studies for patients with colorectal cancer, breast …

… evidence that antiviral drugs can be potential candidates for CRC treatment, … the antitumor
activity of this drug in cancer cells. Currently, a Phase II clinical trial in patients with metastatic …